202 related articles for article (PubMed ID: 23943295)
1. Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.
Taguchi Y; Hohsfield LA; Hollister JR; Baron GS
Chembiochem; 2013 Sep; 14(13):1597-610, 1510. PubMed ID: 23943295
[TBL] [Abstract][Full Text] [Related]
2. Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.
Taguchi Y; Shi ZD; Ruddy B; Dorward DW; Greene L; Baron GS
Mol Biol Cell; 2009 Jan; 20(1):233-44. PubMed ID: 18987338
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
4. Tetracysteine-tagged prion protein allows discrimination between the native and converted forms.
Gaspersic J; Hafner-Bratkovic I; Stephan M; Veranic P; Bencina M; Vorberg I; Jerala R
FEBS J; 2010 May; 277(9):2038-50. PubMed ID: 20345906
[TBL] [Abstract][Full Text] [Related]
5. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
6. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
7. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Coleman BM; Nisbet RM; Han S; Cappai R; Hatters DM; Hill AF
Biochem Biophys Res Commun; 2009 Mar; 380(3):564-8. PubMed ID: 19285001
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides.
Chabry J; Caughey B; Chesebro B
J Biol Chem; 1998 May; 273(21):13203-7. PubMed ID: 9582363
[TBL] [Abstract][Full Text] [Related]
9. Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells.
Nakamitsu S; Kurokawa A; Yamasaki T; Uryu M; Hasebe R; Horiuchi M
J Gen Virol; 2010 Feb; 91(Pt 2):563-9. PubMed ID: 19812263
[TBL] [Abstract][Full Text] [Related]
10. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres.
Kim NH; Choi JK; Jeong BH; Kim JI; Kwon MS; Carp RI; Kim YS
FASEB J; 2005 May; 19(7):783-5. PubMed ID: 15758042
[TBL] [Abstract][Full Text] [Related]
11. ReAsH/FlAsH labeling and image analysis of tetracysteine sensor proteins in cells.
Irtegun S; Ramdzan YM; Mulhern TD; Hatters DM
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21897361
[TBL] [Abstract][Full Text] [Related]
12. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
13. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
Dirikoc S; Priola SA; Marella M; Zsürger N; Chabry J
J Neurosci; 2007 Sep; 27(36):9537-44. PubMed ID: 17804615
[TBL] [Abstract][Full Text] [Related]
14. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
15. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
16. Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells.
Wegner C; Römer A; Schmalzbauer R; Lorenz H; Windl O; Kretzschmar HA
J Gen Virol; 2002 May; 83(Pt 5):1237-1245. PubMed ID: 11961279
[TBL] [Abstract][Full Text] [Related]
17. Two alternative pathways for generating transmissible prion disease de novo.
Makarava N; Savtchenko R; Baskakov IV
Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
[TBL] [Abstract][Full Text] [Related]
18. RNA molecules stimulate prion protein conversion.
Deleault NR; Lucassen RW; Supattapone S
Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
[TBL] [Abstract][Full Text] [Related]
19. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
20. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171.
Striebel JF; Race B; Meade-White KD; LaCasse R; Chesebro B
PLoS Pathog; 2011 Sep; 7(9):e1002275. PubMed ID: 21980292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
